SCHEMBL3955741

SCHEMBL3955741

c1cnc([C@H]2CCCc3ccccc32)nc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 3/20 0.65
ADRA2A P08913 2/20 0.65
ADRA1D P25100 1/20 0.65
ADRA1B P35368 1/20 0.65
CYP2D6 P10635 2/20 0.56
HTR1A P08908 1/20 0.56
OPRM1 P35372 1/20 0.56
MEN1 O00255 1/20 0.55
ALDH1A1 P00352 1/20 0.55
BLM P54132 1/20 0.55
KMT2A Q03164 1/20 0.55
TAAR1 Q96RJ0 1/20 0.55
GID4 Q8IVV7 1/20 0.47
IDO1 P14902 2/20 0.46
LMNA P02545 1/20 0.42
HAO1 Q9UJM8 1/20 0.42
MAPK1 P28482 1/20 0.41
MAPK14 Q16539 1/20 0.41
HDAC6 Q9UBN7 1/20 0.40
KCNN3 Q9UGI6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9814150 1.00 ADRA1A (0.65) ADRA1AADRA2AADRA1DADRA1BCYP2D6
SCHEMBL3962724 1.00 ADRA1A (0.65) ADRA1AADRA2AADRA1DADRA1BCYP2D6
SCHEMBL8086470 0.89 ADRA1A (0.63) ADRA1AADRA2AADRA1DADRA1BCYP2D6
SCHEMBL7560459 0.86 ADRA1A (0.57) ADRA1AADRA2AADRA1DADRA1BCYP2D6
SCHEMBL4204524 0.85 ADRA1A (0.59) ADRA1AADRA2AADRA1DADRA1BCYP2D6
SCHEMBL3171152 0.84 ADRA1A (0.59) ADRA1AADRA2AADRA1DADRA1BCYP2D6
SCHEMBL30268068 0.83 ADRA1A (0.55) ADRA1AADRA2AADRA1DADRA1BCYP2D6
SCHEMBL30268228 0.83 ADRA1A (0.55) ADRA1AADRA2AADRA1DADRA1BCYP2D6
SCHEMBL13726791 0.83 ADRA1A (0.55) ADRA1AADRA2AADRA1DADRA1BCYP2D6
SCHEMBL769101 0.79 ADRA1A (1.00) ADRA1AADRA2AADRA1DADRA1BCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7550473-B2 Pyrimidine derivatives useful as inhibitors of PKC-theta BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2009-06-23 US disclosed
US-20050124640-A1 Pyrimidine derivatives useful as inhibitors of PKC-theta BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124640-A1 Pyrimidine derivatives useful as inhibitors of PKC-theta PRKCQ, PRKCZ, PRKCH ADRA1A 1128/4885ADRA2A 825/4885ADRA1D 1112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.